These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10691206)

  • 1. Comparative in vitro activity of quinolones against Stenotrophomonas maltophilia.
    Valdezate S; Vindel A; Baquero F; Cantón R
    Eur J Clin Microbiol Infect Dis; 1999 Dec; 18(12):908-11. PubMed ID: 10691206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of clinafloxacin in comparison with other quinolones against Stenotrophomonas maltophilia clinical isolates in the presence and absence of reserpine.
    Ribera A; Jurado A; Ruiz J; Marco F; Del Valle O; Mensa J; Chaves J; Hernández G; Jiménez de Anta MT; Vila J
    Diagn Microbiol Infect Dis; 2002 Feb; 42(2):123-8. PubMed ID: 11858908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative activity of new quinolones against 326 clinical isolates of Stenotrophomonas maltophilia.
    Weiss K; Restieri C; De Carolis E; Laverdière M; Guay H
    J Antimicrob Chemother; 2000 Mar; 45(3):363-5. PubMed ID: 10702558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance of Stenotrophomonas maltophilia to Fluoroquinolones: Prevalence in a University Hospital and Possible Mechanisms.
    Jia W; Wang J; Xu H; Li G
    Int J Environ Res Public Health; 2015 May; 12(5):5177-95. PubMed ID: 25985315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial susceptibility profile of molecular typed cystic fibrosis Stenotrophomonas maltophilia isolates and differences with noncystic fibrosis isolates.
    Cantón R; Valdezate S; Vindel A; Sánchez Del Saz B; Maíz L; Baquero F
    Pediatr Pulmonol; 2003 Feb; 35(2):99-107. PubMed ID: 12526070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of moxifloxacin against Stenotrophomonas maltophilia blood isolates from patients with hematologic malignancies.
    Venditti M; Monaco M; Micozzi A; Tarasi A; Friedrich A; Martino P
    Clin Microbiol Infect; 2001 Jan; 7(1):37-9. PubMed ID: 11284945
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative in vitro activity of levofloxacin and ciprofloxacin against bacterial isolates from neutropenic patients.
    Di Bonaventura G; D'Antonio D; Catamo G; D'Ercole S; Piccolomini R
    Chemotherapy; 2002 Jul; 48(3):134-7. PubMed ID: 12138329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular epidemiology of Stenotrophomonas maltophilia strains isolated from paediatric patients].
    Köseoğlu O; Sener B; Gür D
    Mikrobiyol Bul; 2004; 38(1-2):9-19. PubMed ID: 15293897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial susceptibility profile of contemporary clinical strains of Stenotrophomonas maltophilia isolates: can moxifloxacin activity be predicted by levofloxacin MIC results?
    Galles AC; Jones RN; Sader HS
    J Chemother; 2008 Feb; 20(1):38-42. PubMed ID: 18343741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of levofloxacin and ciprofloxacin on biofilms and planktonic cells of Stenotrophomonas maltophilia isolates from patients with device-associated infections.
    Passerini de Rossi B; García C; Calenda M; Vay C; Franco M
    Int J Antimicrob Agents; 2009 Sep; 34(3):260-4. PubMed ID: 19362452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial susceptibility of stenotrophomonas maltophilia isolates from Korea, and the activity of antimicrobial combinations against the isolates.
    Chung HS; Hong SG; Kim YR; Shin KS; Whang DH; Ahn JY; Park YJ; Uh Y; Chang CL; Shin JH; Lee HS; Lee K; Chong Y
    J Korean Med Sci; 2013 Jan; 28(1):62-6. PubMed ID: 23341713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in gyrA and parC QRDRs are not relevant for quinolone resistance in epidemiological unrelated Stenotrophomonas maltophilia clinical isolates.
    Ribera A; Doménech-Sanchez A; Ruiz J; Benedi VJ; Jimenez de Anta MT; Vila J
    Microb Drug Resist; 2002; 8(4):245-51. PubMed ID: 12523620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of eight fluoroquinolones against multiresistant Stenotrophomonas maltophilia.
    Sánchez-Hernández J; Manzanares MA; Gutiérrez Zufiaurre MN; Muñoz Criado S; Muñoz Bellido JL; García-Rodríguez JA
    Rev Esp Quimioter; 1999 Sep; 12(3):234-6. PubMed ID: 10878514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial activities of gatifloxacin against nosocomial isolates of Stenotrophomonas maltophilia measured by MIC and time-kill studies.
    Cohn ML; Waites KB
    Antimicrob Agents Chemother; 2001 Jul; 45(7):2126-8. PubMed ID: 11408235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infection and colonization by Stenotrophomonas maltophilia: antimicrobial susceptibility and clinical background of strains isolated at a tertiary care centre in Hungary.
    Juhász E; Krizsán G; Lengyel G; Grósz G; Pongrácz J; Kristóf K
    Ann Clin Microbiol Antimicrob; 2014 Dec; 13():333. PubMed ID: 25551459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levofloxacin in vitro activity and time-kill evaluation of Stenotrophomonas maltophilia clinical isolates.
    Bonfiglio G; Cascone C; Azzarelli C; Cafiso V; Marchetti F; Stefani S
    J Antimicrob Chemother; 2000 Jan; 45(1):115-7. PubMed ID: 10629022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial susceptibilities of a worldwide collection of Stenotrophomonas maltophilia isolates tested against tigecycline and agents commonly used for S. maltophilia infections.
    Farrell DJ; Sader HS; Jones RN
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2735-7. PubMed ID: 20368399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro susceptibility of Stenotrophomonas maltophilia isolates: comparison of disc diffusion, Etest and agar dilution methods.
    Nicodemo AC; Araujo MR; Ruiz AS; Gales AC
    J Antimicrob Chemother; 2004 Apr; 53(4):604-8. PubMed ID: 14973153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-vitro activity of trovafloxacin against clinical bacterial isolates from patients with cancer.
    Rolston KV; Ho DH; LeBlanc B; Streeter H; Dvorak T
    J Antimicrob Chemother; 1997 Jun; 39 Suppl B():15-22. PubMed ID: 9222065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Accumulation and efflux of quinolones by clinical isolates of Stenotrophomonas maltophilia].
    Sánchez P; Alonso A; Campanario E; Alós I; Martíinez JL
    Rev Esp Quimioter; 2000 Jun; 13(2):176-81. PubMed ID: 10918091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.